AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Index of articles > Business > Trade Industries publications > Chemical Business Newsbase articles > December 2005 articles
Close

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-140570537/alpharma-completes-sale-global.html" title="Facts and information about Alpharma completes sale of global generics business to Actavis Group for $810 M.">Alpharma completes sale of global generics business to Actavis Group for $810 M.</a>
Close Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
XML Add to My Yahoo! Add to My AOL Add to Google Subscribe in NewsGator
Frequently asked questions about RSS feeds

Alpharma completes sale of global generics business to Actavis Group for $810 M.

Chemical Business Newsbase

| December 19, 2005 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

(From Chemical Business NewsBase - Press Release)

Alpharma Inc completed its previously announced sales of its US and International Generics businesses to Actavis Group on a debt-free and cash-free basis for $810 M in cash. The company is retaining ownership of its Branded Pharmaceuticals, Active Pharmaceutical Ingredients, and Animal Health businesses, as well as ParMed Pharmaceuticals Inc, its US pharmaceutical distribution business. The divestiture will improve Alpharma's …

View articles courtesy of your local library
Related articles from newspapers, magazines, journals, and more
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily